Rahul Saluja, Senior Executive and Thought Leader in Life Sciences.

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Discover how Generative AI is revolutionizing healthcare by boosting data integration, enhancing patient care, accelerating ...

"AI has made remarkable strides by streamlining menial, non-value-added services and increasing accuracy," he said. "It has demonstrated substantial positive effects on non-clinical operations, ...

In April 2024, the US Department of Health and Human Services (HHS) issued a final rule reinterpreting Section 1557 of the Affordable Care Act, ...

One of GPT-4’s key strengths lies in its ability to extract explicit and straightforward information from medical notes. The ...

In today’s rapidly advancing digital landscape, Santhosh Kumar Pendyala highlights a transformative era in emergency care ...

RAG takes large language models a step further by drawing on trusted sources of domain-specific information. This brings ...

California Attorney General Rob Bonta (the California AG) issued two Legal Advisories regarding the utilization of ...

In 2016, ahead of the US presidential election, the National Academy of Medicine launched the strategic initiative Vital Directions for Health and Health Care—a series of papers on critical areas of ...

Researchers from Emory University have developed a robust AI-powered meta-model designed to predict the likelihood of blood ...